These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 7778548

  • 1. Lack of long-term ventricular arrhythmia reduction by enalapril in heart failure. SOLVD Investigators.
    Pratt CM, Gardner M, Pepine C, Kohn R, Young JB, Greenberg B, Capone R, Kostis J, Henzlova M, Gosselin G.
    Am J Cardiol; 1995 Jun 15; 75(17):1244-9. PubMed ID: 7778548
    [Abstract] [Full Text] [Related]

  • 2. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D.
    Circulation; 1993 Nov 15; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [Abstract] [Full Text] [Related]

  • 3. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
    Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D.
    Circulation; 1992 Aug 15; 86(2):431-8. PubMed ID: 1638712
    [Abstract] [Full Text] [Related]

  • 4. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.
    Rogers WJ, Johnstone DE, Yusuf S, Weiner DH, Gallagher P, Bittner VA, Ahn S, Schron E, Shumaker SA, Sheffield LT.
    J Am Coll Cardiol; 1994 Feb 15; 23(2):393-400. PubMed ID: 8294693
    [Abstract] [Full Text] [Related]

  • 5. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
    Böhm M, Pogue J, Kindermann I, Pöss J, Koon T, Yusuf S.
    Eur J Heart Fail; 2014 Mar 15; 16(3):325-33. PubMed ID: 24464788
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators.
    Benedict CR, Francis GS, Shelton B, Johnstone DE, Kubo SH, Kirlin P, Nicklas J, Liang CS, Konstam MA, Greenberg B.
    Am J Cardiol; 1995 Jun 01; 75(16):1151-7. PubMed ID: 7762503
    [Abstract] [Full Text] [Related]

  • 9. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators.
    Kostis JB, Shelton B, Gosselin G, Goulet C, Hood WB, Kohn RM, Kubo SH, Schron E, Weiss MB, Willis PW, Young JB, Probstfield J.
    Am Heart J; 1996 Feb 01; 131(2):350-5. PubMed ID: 8579032
    [Abstract] [Full Text] [Related]

  • 10. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.
    Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI.
    Lancet; 2003 May 31; 361(9372):1843-8. PubMed ID: 12788569
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
    Parker AB, Yusuf S, Naylor CD.
    Am Heart J; 2002 Dec 31; 144(6):941-7. PubMed ID: 12486418
    [Abstract] [Full Text] [Related]

  • 16. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
    Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A.
    Circulation; 2003 Jun 17; 107(23):2926-31. PubMed ID: 12771010
    [Abstract] [Full Text] [Related]

  • 17. Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril.
    Sturm B, Pacher R, Strametz-Juranek J, Berger R, Frey B, Stanek B.
    Eur J Heart Fail; 2000 Dec 17; 2(4):407-12. PubMed ID: 11113718
    [Abstract] [Full Text] [Related]

  • 18. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).
    Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif JC, Studies Of Left Ventricular Dysfunction.
    Circulation; 2003 Mar 11; 107(9):1291-6. PubMed ID: 12628950
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
    Szucs TD, Goedde M, Berger K, Kiowski W.
    Schweiz Med Wochenschr; 1997 Jul 22; 127(29-30):1234-41. PubMed ID: 9333933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.